Specify a stock or a cryptocurrency in the search bar to get a summary
Global X China Biotech Innovation ETF
CHBGlobal X China Biotech Innovation ETF, a constituent of the ETF, is listed on the NASDAQ. Its market capitalization stands at 1 412 023 USD. Over the past year, it has generated a yield of -100.00 %. The fund's net expense ratio, a critical measure of operational efficiency, is recorded at 0.65 %. A significant allocation in cash assets underscores its liquidity position and risk management strategy. Turning to technical indicators, they offer a granular perspective on the fund's market behavior, historical trends, and potential forward momentum. For an in-depth analysis get premium access.